Results 61 to 70 of about 438 (257)

Ultralow-frequency Waves in Jupiter’s Magnetopause Boundary Layer

open access: yesThe Astrophysical Journal
Ultralow-frequency (ULF) waves (∼tens of minutes period) are widely identified in the Jovian system and are believed to be associated with energy dissipation in the magnetosphere and ionosphere.
Zhili Zeng   +6 more
doaj   +1 more source

Precipitating electron properties of Ganymede’s aurora retrieved from Juno/UVS observations during PJ34

open access: yesAstronomy & Astrophysics
Context. Ganymede’s UV aurorae, observed by HST and Juno/UVS, trace interactions between its atmosphere and Jupiter’s magneto-sphere. These emissions, dominated by O I lines at 130.4 and 135.6 nm, are driven by electron impact on species such as H2O, O ...
Benmahi B.   +20 more
doaj   +1 more source

Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling

open access: yesAnnals of Neurology, EarlyView.
Objective Age of symptom onset is highly variable in familial frontotemporal lobar degeneration (f‐FTLD). Accurate prediction of onset would inform clinical management and trial enrollment. Prior studies indicate that individualized maps of brain atrophy can predict conversion to dementia in f‐FTLD.
Shubir Dutt   +82 more
wiley   +1 more source

Aurora records in the Spanish newspaper Extremadura for the period 1923–2017 [PDF]

open access: yesHistory of Geo- and Space Sciences
Aurora records are a valuable proxy for understanding historical solar behavior. This study explores historical records of auroras reported in the Spanish newspaper Extremadura from 1923 to 2017.
C. Sánchez Romero   +11 more
doaj   +1 more source

Auditory Hyperresponsivity in Chronic Back Pain: A Randomized Controlled Trial of Pain Reprocessing Therapy

open access: yesAnnals of Neurology, EarlyView.
Objective Heightened sensitivity to noxious stimulation is a hallmark of chronic pain. Emerging evidence suggests heightened unpleasantness to non‐noxious (eg, auditory) aversive stimulation also characterizes chronic pain, but its magnitude, neural mechanisms, and treatment modifiability remain unknown.
Alina E. C. Panzel   +4 more
wiley   +1 more source

Saturn’s Recurrent Auroral Flashes in the Equinoctial Campaign

open access: yesThe Astrophysical Journal
The past decades of Cassini’s investigation around Saturn have revealed the frequent occurrence of ∼1 hr quasiperiodic (QP) signatures in the in situ magnetic field and plasma measurements and plasma wave observations. Saturn’s aurora, as the response to
Tianshu Qin   +4 more
doaj   +1 more source

Aurora

open access: yesEos, Transactions American Geophysical Union, 1973
The polar aurora is perhaps the most fascinating and mysterious of the many spectacles that Nature puts up for us to observe. Only direct observation can reveal its three‐dimensional grandeur, but some of the beauty can be captured in color photographs such as those included with this article (taken by Gustav Lamprecht of College, Alaska).
openaire   +1 more source

A Doxorubicin‐Loaded Liposomes Baghdadite System for Localized Osteosarcoma Therapy and Bone Regeneration

open access: yesAdvanced NanoBiomed Research, EarlyView.
This study presents a multifunctional Baghdadite ceramic implant integrating doxorubicin‐loaded liposomes via ion‐assisted plasma polymer coating for localized osteosarcoma therapy. The platform enables drug retention, sustained release, tumor cell inhibition, osteoconductivity, and antibacterial activity, offering a mechanically robust strategy for ...
Sally Kortam   +8 more
wiley   +1 more source

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

open access: yesArthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane   +33 more
wiley   +1 more source

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

open access: yesArthritis &Rheumatology, EarlyView.
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy